Prescription drug · ANDA
Lithium Carbonate Lithium Carbonate (Lithium carbonate) NDC 62332-015
Lithium carbonate 600 mg/1 · Capsule · Oral · Alembic Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62332-015-30 | 62332001530 | 30 CAPSULE in 1 BOTTLE (62332-015-30)Marketed from Dec 27, 2016 | |
| 62332-015-31 | 62332001531 | 100 CAPSULE in 1 BOTTLE (62332-015-31)Marketed from Dec 27, 2016 | |
| 62332-015-71 | 62332001571 | 500 CAPSULE in 1 BOTTLE (62332-015-71)Marketed from Dec 27, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lithium Carbonate Lithium CarbonateSuffix: LITHIUM CARBONATE
- Generic name (nonproprietary)
- lithium carbonate
- Active ingredients
- Lithium carbonate — 600 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Alembic Pharmaceuticals Inc.NDC labeler code 62332
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 079159
- Marketing start
- Listing expires
- Identifiers
- Product ID 62332-015_b1af5294-98eb-4c2c-9178-a057386fb3f7SPL ID b1af5294-98eb-4c2c-9178-a057386fb3f7SPL set ID 4ca2b977-b94c-4232-9b7e-835db97c9544RxCUI 197889, 197893, 311355UNII 2BMD2GNA4VUPC 0362332015306, 0362332013302, 0362332014309
- Pharmacologic class
- Mood Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462332001530followed by a unit qualifier and the quantityPackage 62332-0015-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies (14)] Maintenance treatment in patients 7 years and older [see Clinical Studies (14)]. Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older (1) Maintenance treatment in patients 7 years and older (1)
Excerpt only. Read the full label for complete information.
About NDC 62332-015
- What is NDC 62332-015?
- 62332-015 is the product NDC for Lithium Carbonate Lithium Carbonate, Lithium carbonate 600 mg/1 capsule, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lithium Carbonate Lithium Carbonate (Lithium carbonate).
- What is the active ingredient?
- Lithium carbonate.
- Who is the labeler?
- Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lithium Carbonate Lithium Carbonate?
- 2 other product NDCs are listed under this name. See all Lithium Carbonate Lithium Carbonate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lithium Carbonate Lithium Carbonate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lithium Carbonate Lithium Carbonatelithium carbonate | Lithium carbonate 150 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-013 | 62332-0013-3062332-0013-3162332-0013-71+1 more |
| Lithium Carbonate Lithium Carbonatelithium carbonate | Lithium carbonate 300 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-014 | 62332-0014-3062332-0014-3162332-0014-71+1 more |
Other NDCs under ANDA 079159
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lithium Carbonate | Lithium carbonate 150 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-303 |
| Lithium Carbonate | Lithium carbonate 300 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-304 |
| Lithium Carbonate | Lithium carbonate 600 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-305 |
| Lithium Carbonate Lithium Carbonatelithium carbonate | Lithium carbonate 150 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-013 |
| Lithium Carbonate Lithium Carbonatelithium carbonate | Lithium carbonate 300 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-014 |